A personal injury lawsuit (product liability lawsuit) or a wrongful death lawsuit against any large pharmaceutical company like British pharmaceutical giant GlaxoSmithKline is a very serious undertaking, and there may be other potential defendants in the distribution chain that share in the liability.The Willis Law Firm has been sucessful in 100's of claims and lawsuits against most of the drug giants, inckuding GSK.

As to an Advair death lawsuit the Willis Law Firm in Houston is currently represently a number of families tht have lost their children as a result of a sudden asthmatic death. Each of these childen were using an Advair inhaler. Additionally, the Willis Law Firm is representing a mother of a young boy that was left brain damaged as a result of a sudden asthmatic attack that left him in near death condition in which he lost oxygen to the brain rendering him seriously brain damaged and blind due to oxgyen deprived. In each of the sudden death cases and the brain damage case it is our belief that these children's death was preventable if they had not been prescribed the Advair inhaler.

Advair FDA Warnings

The Food and Drug Administration (FDA), on November 15, 2005 issued a public Advair warning about potentially fatal side effects from two GlaxoSmithKline asthma drugs. The agency is asking the maker of the drugs, Advair Diskus and Serevent Diskus, to add warnings to their labels that these medications "may increase the chance of severe asthma episodes, and death when those episodes occur.". Although they can reduce the number of asthma episodes, the FDA says they "may increase the chances of a severe asthma episode when they do occur." Earlier In August 2003, the FDA announced the addition of new safety information and warnings to the labeling for drug products that contain salmeterol. The new labeling includes a boxed warning about a small, but significant, increased risk of life-threatening asthma episodes or asthma-related deaths observed in patients taking salmeterol in a recently completed large U.S. safety study.